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A differentiating system based on embryonic stem (ES) cell-derived embryoid bodies (EBs) which recapitulates the in vivo
cardiac, skeletal, and smooth muscle myogenesis of mouse embryos was developed and used to investigate the effects of
the disruption of the desmin gene on muscle cell differentiation. Wild-type, heterozygous, and homozygous cell lines with
the mutated desmin allele were evaluated. Skeletal myogenesis was totally inhibited in desmin null mutant EBs, as
manifested by the absence of myotube formation, contractility, and myoD, myogenin, myf5, and myosin heavy chain
expression. Smooth muscle formation was also completely blocked in the absence of desmin. On the other hand, there
were no obvious effects on cardiomyocyte differentiation in these desmin null mutant EBs. However, reduced desmin
expression in EBs heterozygous for the desmin mutation leads to partial inhibition of cardiac muscle formation. These
data suggest that in contrast to early cardiocyte differentiation, desmin is indispensable for skeletal and smooth muscle
formation. q 1995 Academic Press, Inc.
INTRODUCTION sion during differentiation and development (for review
see Olson, 1990; Weintraub, 1991; Emerson, 1993; Lassar
and Munsterberg, 1994; and Olson and Klein, 1994; BraunUnderstanding the mechanisms that control embryonic
et al., 1992; Rudnicki et al., 1992; Hasty et al., 1993;development requires extensive knowledge of both gene
Nabeshima et al., 1993; Zhang et al., 1995; Braun andactivation mechanisms and signaling processes at multi-
Arnold, 1995). We still do not know, however, the signal-cellular levels. During muscle development an embryo
ing mechanisms responsible for the activation of thesemust coordinate cell division, cell migration, cell recogni-
regulators. A variety of independent observations havetion, cell adhesion, cell fusion, and ultimately, formation
suggested that changes in cell shape due to interactionsof a properly functioning muscle. During these develop-
with either the extracellular matrix or neighboring cellsmental processes signals by extracellular morphogens, ex-
lead to reorganization of the cytoskeleton that causestracellular matrix, and direct cell-to-cell interactions
changes in gene expression, possibly by directly inter-must be sensed by the cells through different cell signal-
acting with the nuclear matrix or by activating and facili-ing molecules and transmitted to the nucleus where, in
tating the transport of regulatory factors to the nucleuscoordination with internal signals, induction of muscle-
(for review see Ingber, 1993; Benya and Shaffer, 1982; Bis-speci®c gene expression takes place. The discovery of the
sel et al., 1982; Clayton et al., 1985 Stoker et al., 1990;myogenic helix-loop-helix (mHLH) transcription regula-
Ben-Ze'ev, 1991; Wang et al., 1993; Li et al., 1994; Lin ettors, myoD, myogenin, MRF4, and myf5 and the analysis
al., 1995; Rosette and Karin, 1995; Streuli et al., 1995;of their gene targeted mutants has contributed enor-
Tremble et al., 1995).mously in our understanding of the molecular mechanism
The cytoskeleton of the higher eukaryotic cell is com-responsible for activation of muscle-speci®c gene expres-
posed of three different ®lamentous networks: microtu-
bules, actin micro®laments, and intermediate ®laments
(IF). The different members of the IF superfamily show very1 Current address: Institute for Biochemistry, University of Vi-
restricted tissue speci®c and developmentally regulated ex-enna, Vienna, Austria.
2 To whom correspondence should be addressed. pression (for review see Fuchs and Weber, 1994). This
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unique expression pattern distinguishes IF from the other kinases that seem to be involved in signal transduction (for
review see Eriksson et al., 1992). Finally, recent data ontwo cytoskeletal networks and its biological signi®cance
has not been revealed yet (for review see Traub and Shoe- mechanotransduction across the cell surface and through
the cytoskeleton, including the intermediate ®lament sys-man, 1994; Klymkowsky, 1995).
Desmin is the muscle-speci®c IF protein (Lazarides and tem (Wang et al., 1993; for review see Ingber, 1993), favor
this hypothesis.Hubbard, 1976). It is encoded by a single copy gene (Capeta-
naki et al., 1984) which is expressed in all muscle tissues, Several experimental approaches have attempted to eluci-
date the functions of intermediate ®laments in vivo. Forcardiac, skeletal, and smooth (for review see Lazarides et
al., 1982, and Lazarides and Capetanaki, 1986). It is one of example, it has been shown that the overexpression of vi-
mentin in the lens of transgenic mice increases proliferationthe earliest known myogenic markers both in heart and in
somites (Kaufman and Foster, 1988; Herrmann et al., 1989; and inhibits lens ®ber differentiation, including cell elonga-
tion and enucleation (Capetanaki et al., 1989). These dataSchaart et al., 1989; Choi et al., 1990; Lin et al., 1994).
During mouse development, desmin ®rst appears at 8.25 suggested that this growth-regulated intermediate ®lament
protein modulates transitions from proliferation to differen-days postcoitum (d.p.c.) in the neuroectoderm, where it is
transiently expressed with vimentin and keratins. At 8.5 tiation. On the other hand, as recently reported, a vimentin
null mouse can develop with no obvious abnormal pheno-d.p.c. it appears in the heart rudiment, and at Day 9 it can
be detected in the myotome (FuÈ rst et al., 1989, Schaart et type (Colucci-Guyon et al., 1994). Ectopic expression of des-
min in the lenses of transgenic mice causes, among otheral., 1989). In contrast to most muscle-speci®c genes, desmin
is also expressed at low levels in satellite cells (Allen et al., abnormalities, partial plasma membrane fusion (Krimpenf-
ort et al., 1988; Dunia et al., 1990). From the desmin anti-1991) and replicating myoblasts (Kaufman and Foster, 1988).
During development desmin expression precedes all the sense RNA studies in C2C12 myoblasts so far, we know
that desmin is necessary for the formation of myotubes inother muscle-speci®c structural genes and the myogenic
HLH transcription factors myoD, myogenin, and MRF4, tissue culture (Li et al., 1994); however, virtually nothing
is known about desmin's role in smooth muscle cells andwith the exception of Myf-5 (for review see Arnold and
Braun, 1993; Sassoon, 1993; Lyons and Buckingham, 1992, cardiocytes or its role in vivo, particularly at the very early
stages of myogenic differentiation during embryonic devel-1993; Li et al., 1993), suggesting that it might play some
modulating role in myogenic commitment and differentia- opment.
To investigate the role of desmin in all three types oftion. Recent studies using antisense RNA to inhibit desmin
in differentiating C2C12 myoblasts has provided some ex- muscle cells, we mutated both desmin alleles in embryonic
stem cells. These cells can be induced to differentiate inperimental evidence in support of this hypothesis, since
desmin inhibition not only blocked myoblast fusion but vitro into structures known as embryoid bodies (EB). Al-
though the differentiation is chaotic, embryoid bodies ex-also reduced considerably the expression of the myogenic
transcription regulators myoD and myogenin (Li et al., hibit a variety of differentiated cell types derived from the
three germ layers, including muscle. The differentiation of1994). Older morphological data have suggested that desmin
is required to form a transcytoplasmic integrating matrix EBs which lacked both desmin alleles was evaluated. The
formation of beating cardiomyocyte aggregates and con-responsible for keeping myo®brils in lateral alignment
(Granger and Lazarides, 1979; for review see Lazarides and tracting skeletal and smooth muscle tissues in wild-type
EBs and EBs heterozygous and homozygous for the desminCapetanaki, 1986). However, in vitro data have shown that
disruption of desmin/vimentin ®laments does not interfere mutation was compared. Skeletal and smooth muscle for-
mation is reduced in heterozygous EBs and totally inhibitedwith the lateral alignment and maintenance of the striated
contractile myo®bers (Schultheiss et al., 1991). The possi- in desmin null mutant EBs. On the other hand, there are
no obvious effects on early events of cardiac cell differentia-bility that desmin might be involved in signal transduction
and transport processes between the cell surface and the tion in desmin null mutant EBs; however, expression of
reduced desmin in heterozygous cell lines leads to cardio-nucleus is supported by several pieces of recent information,
including its position in the cell where it interlinks the cyte arrhythmic beating and partially inhibited cardiomyo-
cyte formation in EBs.sarcolemma with the nuclear envelope by speci®cally bind-
ing to ankyrin, other components of the costameres, and
lamin B, respectively (for review see Lazarides and Capeta-
naki, 1986, and Price, 1992; Nelson and Lazarides, 1984; MATERIALS AND METHODS
Tokuyasu et al., 1984; Georgatos et al., 1987; Georgatos
and Blobel, 1987a,b; Lockard and Bloom, 1993). Lamin B Targeted Disruption of Both Desmin Alleles in
binds to the nuclear matrix-associated regions (MARs) (Lud- Embryonic Stem Cells by Homologous
eÁrus et al., 1992) which can activate gene transcription by Recombination
binding to the nuclear matrix (Stief et al., 1989). Further-
more, it was very recently reported that lamin A and desmin A 6.5-kb EcoRI fragment of the mouse desmin gene was
isolated from a Balb/c genomic DNA Charon 4A library (Lican also speci®cally bind MARS in vitro (Luderus et al.,
1994). On the other hand, intermediate ®laments serve both and Capetanaki, 1993). This fragment, which contains ex-
ons 1 to 6, was ligated to a thymidine kinase (tk) expressionas sites of attachment as well as major substrates of several
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cassette at its 5* end and cloned into pBluescript(KS0) (Stra- The medium was changed every 3 days until Day 33 after
aggregation. Each time 13 of the old medium was mixed withtagene). The neo cassette from pMCIneopA (Thomas and
Capecchi, 1987) was excised with XhoI and SalI and inserted 8 ml M15 (Days 7 and 10), 10 ml M15 (Days 13, 16, 19, and
between two XhoI sites located 107 and 142 bp downstream 22), and 12 ml M15 (Days 25, 28, and 31). Differentiating EBs
from the start codon in exon 1 (Li, et al., 1994). Both marker were checked daily for cardiac skeletal and smooth muscle
cassettes were oriented in the direction opposite to desmin. tissue. The approximate number of cardiocyte aggregates,
The 3* part of exon 1 (basepairs 142 to 607 (SalI site)), down- groups of myotubes, and smooth muscle cell aggregates per
stream of the inserted neo cassette was removed to delete embryoid body were 5±10, 2±4, and 3±5, respectively. The
an internal start codon. Prior to transfection this construct number of myotubes per group could not be easily esti-
(ptkneodes) was linearized at a unique NotI restriction site mated; it was at least 40.
situated in the plasmid backbone.
ES cell lines AB1 (McMahon and Bradley, 1990) and AB2.1
Indirect Double Immuno¯uorescence Staining(Soriano et al., 1991) were cultured on mitotically inacti-
vated mouse embryonic ®broblast STO feeder cell line EBs attached to gelatinized coverslips were ®xed in abso-
SNL76/7 (McMahon and Bradley, 1990) as previously de- lute ethanol at 0207C for 5 min, air dried, and incubated
scribed (Roberson, 1987). For electroporation exponentially with the different monoclonal antibodies (desmin (D3),
growing ES cells were trypsinized for 20 min, resuspended MyoD, myogenin (F5D), MHC (MF20)), smooth muscle ac-
at a concentration of 1.1 1 107 cells/ml in PBS, and electro- tin (A2547), and calponin (C2687) in a humidi®ed chamber
porated at room temperature with 0.025 mg linearized DNA at room temperature for 14 to 16 hr. The EBs were washed
in one milliliter at 575V/cm, 500 mF, using a Bio-Rad gene with PBS, for 6 to 12 hr, then incubated with a mixture of
pulser. Five minutes after electroporation, 107 cells were FITC and TR conjugated secondary antibodies in a humidi-
plated onto a 10-cm SNL76/7 feeder plate (McMahon and ®ed chamber at room temperature for 6 hr, and ®nally
Bradley, 1990), allowed to recover for 24 hr, and selected washed with PBS for 2 to 6 hr. Myf5 staining was performed
for resistance in the presence of 0.18 mg of G418(active as previously described (Block and Miller, 1992). Nuclei
ingredient) (Geneticin, Gibco) per milliliter and 200 nM were stained with 20 ng/ml DAPI in PBS for 30 sec, followed
FIAU (1-(2*-deoxy-2*-¯uoro-b-D-arabinofuranosyl)-5-iodo- by washing EBs twice with PBS for 10 min. Specimens were
uracil, Occlasen) for 10±14 days for a homologous recombi- mounted in Mowiol and photographed using an Axiophot
nation event. Targeted disruption of the desmin locus was microscope.
con®rmed by Southern blotting (Maniatis et al., 1982).
Probes were prepared from the 5* region of the desmin gene
external to the sequence used in the targeting vector, from RESULTS
the neo cassette, and from a cDNA clone containing Exon
2 to 9 (see Figure 1A). Targeted Disruption of the Desmin Gene
Targeted cell lines with a heterozygous knockout of the in ES Cells
desmin gene were further selected at 1.0 mg/ml G418 (ac-
tive ingredient) for 15 days to select for clones which had The genomic structure of the mouse desmin gene is illus-
trated in Fig. 1A. The gene contains nine exons and hastwo mutant and no wild-type alleles (Mortensen et al.,
1992). Surviving G418-resistant colonies were expanded for an organization which is typical for intermediate ®lament
genes (Quax et al., 1985). To mutate the desmin gene, a4 days without G418 to increase their size before clonal
isolation. Disruption of the second desmin allele was veri- replacement vector (Thomas and Capecchi, 1987) with 6.5
kb of DNA homologous to the chromosomal target was®ed by Southern blotting. mRNA levels were assayed by
Northern blotting (Maniatis et al., 1982) and protein levels constructed. The pMC1neopA expression cassette (Thomas
and Capecchi, 1987), which serves to select transformedwere determined by Western blotting. Cell lines used for in
vitro differentiation experiments were subcloned to exclude cells and mutate the gene, was inserted into the ®rst coding
exon of the desmin gene in the opposite transcriptional di-clonal contamination.
rection. To exclude the possibility of a partially functional
allele 319 bp of exon one was deleted from the vector. To
Embryoid Body Formation and in Vitro facilitate positive negative selection an HSV-tk gene was
Differentiation included in the targeting vector. This construct, ptkneodes,
should lead to the inactivation of the desmin gene, afterNearly con¯uent ES cells were trypsinized, resuspended
at a density of 2 1 104 cells/ml M15 (DMEM plus 15% fetal double reciprocal recombination (Fig. 1A) The additional
EcoRI site in the neo cassette allows a convenient identi®-calf serum (Sigma, Heart Line, Lot 100H-4611), 0.1 mM
bME, 2 mM glutamine, 0.05 mg/ml streptomycin, and 0.03 cation of the disrupted gene.
Embryonic stem cells (AB2.1) were transfected and doublemg/ml penicillin), and allowed to aggregate into EBs in 20-ml
hanging drop cultures for 4.5 days (Rudnicki and McBurney, resistant clones (G418 and FIAU) were isolated and screened
for gene targeting events by Southern blot analysis. The1987). EBs with a visible outer layer of endodermal cells
(100%) were collected and 90 { 10 EBs plated onto gelati- mutation of the desmin gene was veri®ed by probing EcoRI-
digested genomic DNA with a ¯anking probe (probe A, Fig.nized 10-cm tissue culture dishes in a volume of 8 ml M15.
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FIG. 1. Targeted inactivation of the desmin gene by homologous recombination. (A) Schematic representation of the targeting event. Restriction
maps of the desmin locus, the targeting vectors, and the mutant alleles after homologous recombination. Exons 1 to 9 are indicated by shaded
boxes. The recombination vector contains 6.5 kb of the desmin gene, linked to the HSV-tk gene (tk) and the pBlueskript(SK0) cloning vector
(un®lled boxes). The neo expression cassette (neo) interrupts the desmin coding sequence within the ®rst exon, the 3* part of which, between the
second XhoI and the SalI site, was removed. The newly introduced EcoRI restriction site, located in the neo cassette, is used for the identi®cation
of the targeted clones. The expected restriction fragments before and after gene targeting are shown. Note the gain of the new 5.2-kb EcoRI
fragment in the targeted cells. Arrows indicate the transcriptional orientation of the tk and neo promoters. Origin of probes are indicated by bars.
R, EcoRI; B, BamHI; H, HindIII; X, XhoI; S, SalI; N, NotI. (B) Southern blot analysis of EcoRI-digested, genomic DNA from wild-type, des//des/
(///), heterozygous,desm1// (//0), and homozygous, desm1/desm1 (0/0) for the desmin knockout cell lines using probe A. (C) Northern blot
analysis of Day 12 EBs derived from des/// (///), desm1// (//0), and desm1/desm1 (0/0) cell lines. As controls, RNA from undifferentiated, wild-
type ES cells (ES ///) and differentiated C2C12 myotubes (C2C12 mt) was added. For hybridization probe B was used. RNA from EBs was also
probed with a vimentin cDNA to con®rm loading of equal amounts of RNA. Note that the smaller RNA species (arrowhead), hybridizing with
the desmin cDNA probe, is also expressed in undifferentiated ES cells and, therefore is not related to myogenic events during differentiation. (D)
Western blot analysis of intermediate ®lament preparations from 10-day-old EBs derived from wild-type (///), desm1// (//0), and des//des/ (0/
0) cell lines. Desmin was probed with monoclonal antibody D3. Skel. M., intermediate ®lament preparation from murine thigh muscle. Arrow,
proteolytic fragment of desmin observed in all EB preparations.
1). This probe hybridizes to two fragments: the predicted were targeted, a frequency of about one clone per 106
transfected cells. The recombination event in targeted5.2-kb EcoRI fragment diagnostic of the disrupted allele,
and the 8.5-kb EcoRI fragment from the wild-type allele clones was further con®rmed, using several different restric-
tion enzymes, a cDNA fragment coding for exon 2 to 9(Fig. 1B). Approximately 25% of the double resistant clones
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(probe B), and the neo cassette (probe C) (data not shown). was evident (see Materials and Methods). To induce this
muscle cell differentiation program, EBs formed in hangingThe mutant allele will be referred to as desm1 in order to
distinguish it from future mutations at this locus. drop cultures were transferred to culture dishes on Day 4.5
(Fig. 2A). The endodermal cells of the outer EB cell layersTwo heterozygous ES cell lines with the desm1 allele were
selected for homozygosity at the desmin locus by raising the started to spread within one day (Fig. 2B). On Days 7 to 10
presumptive myoblasts start to fuse and very few expressG418 concentration to 1.0 mg/ml in the culture medium
(Mortensen et al., 1992). In each case approximately 4 1 myosin (data not shown), but do not contribute to any myo-
tube formation because they all die or disappear within 1107 cells were plated under selection and from these around
200 colonies survived, 70 were screened and 10% of the or 2 days, long before the ®rst embryonic myotubes can be
seen in EBs, around Day 14 (Fig. 2C). At Day 8 { 1 severalresistant colonies could be shown to have lost heterozygos-
ity at the desmin locus and had the genotype desm1/desm1. cardyocyte aggregates begin to beat rhythmically in the
dense center of attached EBs (Fig. 2D). Starting from DaySouthern analysis on these clones demonstrated that the
8.5-kb EcoRI fragment of the wild-type desmin allele had 13 { 1, ®rst small and ®ne oligonucleated myotubes, sur-
rounded by myoblasts, appear exclusively at the peripherybeen lost in the homozygous cells. The only fragment which
hybridized to probes A and B was 5.2 kb in length and was of EBs. Shortly after, numerous larger, frequently con-
tracting, polynucleated myotubes are detected (Fig. 2E). Fi-at twice the intensity compared to heterozygous clones (Fig.
1B). The des/// and desm1// cell lines that survived the selec- nally, at Day 14{ 1 slowly contracting smooth muscle cells
are detected, mainly localized in the central region of thetion procedure were used as controls in the differentiation
experiments to exclude any effect on the phenotype caused EBs (Fig. 2F). Smooth muscle is not always as easily detected
as the other muscle types because it tends to appear betweenby the selection procedure.
To con®rm that the mutated allele was null, mRNA and several layers of other cells. Immuno¯uorescence micros-
copy con®rmed the identity of all three types of muscle.protein were analyzed in differentiated cells derived from
desm1/desm1 and desm1// clones. Northern analysis of 12- They all expressed desmin (Figs. 3A, 3D, and 3H). Myosin
heavy chain was found in the contracting cardiocyte nests,day-old EBs showed that there was approximately 50% less
desmin mRNA in EBs from heterozygous (desm1//) cell lines single cardiocytes, and myotubes (Figs. 3B, 3C, and 3E).
Skeletal muscle also expressed the transcription factorscompared with wild-type (des///) EBs, and no desmin
mRNA was detectable in EBs from homozygous cell lines MyoD (Fig. 3F), myogenin (Fig. 3G) and myf5 (Fig. 7), and
smooth muscle cells expressed smooth muscle a-actin (Fig.(desm1/desm1) (Fig. 1C). The smaller RNA species cross-re-
acting with the desmin cDNA probe was also present in 3I) and calponin (Fig. 3J), and typically had elongated nuclei
when stained with DAPI (data not shown). Using these con-wild-type and undifferentiated mutant ES cells. It therefore
seems to be unrelated to desmin RNA. Western blot analy- ditions 85% of the EBs form several rhythmically beating
aggregates of cardiocytes, 60% form frequently contracting,sis of intermediate ®lament preparations from differenti-
ated EBs also showed the expression of approximately 50% polynucleated myotubes, and, demonstrated here for the
®rst time, 25% of the EBs form several very slowly andless desmin protein in EBs derived from desm1// cell lines
compared with wild-type cell lines, and no desmin expres- smoothly contracting areas of tightly attached smooth mus-
cle cells.sion could be detected in the desm1/desm1 EBs (Fig. 1D).
In order to de®ne the timing of myogenesis in EBs and to
compare these data with mouse development in vivo, we
Cardiac, Skeletal, and Smooth Muscle Myogenesis analyzed large numbers of EBs in independent sets of experi-
in Embryoid Bodies ments for muscle cells beating and contracting over a time
period of 33 days (Fig. 4A). The percentage of EBs with beat-Pluripotent ES cells grow as tight aggregates of cells
which can be released into suspension culture to form struc- ing cardiocyte networks reaches a maximum at Day 12.
These cardiocytes survive and continue to beat until Daytures known as EBs. Under appropriate in vitro conditions
EBs recapitulate many of the early embryonic differentia- 20, when they slowly begin to die. Fusion of presumptive
myoblasts and formation of contracting myotubes demon-tion events. The three germ layers form and these can differ-
entiate further into many of the differentiated cell types strate three distinct phases of differentiation. The ®rst peak
(Fig. 4A, peak I) represents very small fused cells with onlyfound in embryos in vivo. For example, in many embryoid
bodies blood islands, visceral yolk sac, cardiac and skeletal few nuclei as shown in Fig. 2C. These fused cells disappear
within 1 or 2 days, and fusion of still small but contractingmuscle cells, and neurons can be identi®ed (Doetschman
et al., 1985; Roberson, 1987). Previous studies have demon- myotubes, which probably correspond to primary myotubes
in embryos, starts. The myotubes of this population in-strated that erythropoietic (Doetschman et al., 1985; Lin-
denbaum and Grosveld, 1990; Burkert et al., 1991) and myo- crease in size and number around Day 14 (Fig. 4A, peak II).
Finally, a second onset of myotube formation takes place.genic differentiation programs (Robbins et al., 1990; San-
chez et al., 1991; Muthuchamy et al., 1993; Rohwedel, 1994) Large areas with dozens of polynucleated myotubes, resem-
bling secondary myotubes in embryos, form and continuecan be similar to those observed during early mouse embryo
development. To evaluate the role of desmin during muscle to contract for several days (Fig. 4A, peak III). Slowly con-
tracting smooth muscle cell arrays reach a maximum atdifferentiation in vitro, embryoid bodies were cultured un-
der conditions in which extensive muscle differentiation Day 16 and continue to contract for about 15 more days.
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FIG. 2. Myogenesis in embryoid bodies. ES cells were transferred to drop cultures and formed EBs with a Reichert's membrane within
4 days. At Day 4.5 EBs were transferred to gelatinized tissue culture dishes. (A) At Day 4.75, cells of the outer endodermal layer attach
to the plate and start to spread. (B) At Days 5 to 6, outgrowing endodermal and ®broblast-like cells surround the growing center of EBs.
(C) At Days 6 to 7, several types of cells appear and some myogenic precursor cells start to fuse and elongate. (D) At Days 7 to 9, cardiocyte
aggregates start to beat rhythmically in the dense center of EBs (arrows). (E) At Days 15 to 20, myotubes form exclusively at the periphery
of EBs and start to contract. (F) At Days 15 to 20, areas of smooth muscle cells, found exclusively in the center of EBs, start a very slow
and ``smooth,'' wavelike contraction. Phase-contrast optics; bars, 100 mm.
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Under our culture conditions, the onset and development
of all muscle tissues in EBs recapitulate the temporal se-
quence of muscle differentiation in mouse embryos (Hogan
et al., 1986). In plates with lower numbers of EBs (less than
50 EBs per 10-cm dish) the EBs were viable for up to 40
days; however, myogenesis in these EBs was signi®cantly
reduced or delayed (data not shown).
The accumulation of the desmin mRNA and protein dur-
ing EB differentiation, monitored by Northern and Western
blot analysis, respectively, corellated well with the state of
muscle differentiation (Figs. 4B and 4C). Low levels of des-
min mRNA were detected on Day 5, reached a maximum
level at Day 9, and remained constant thereafter at least
until Day 19. Similarly, desmin protein could be detected
on Days 6 to 7 in low abundance and reached full levels at
Day 9. The onset of desmin mRNA and protein expression
correlated well also with the corresponding expression pat-
tern in mouse embryos (Li et al., 1993).
Desmin Null Mutation Abolishes Skeletal and
Smooth, but Not Cardiac, Muscle Differentiation
desm1/desm1, desm1//, and wild-type embryoid body cul-
tures were evaluated to de®ne the role of desmin on muscle
cell differentiation. To control for possible artifacts, EBs
were generated from several different independently iso-
lated cell lines with one or both mutant desmin alleles. As
an additional positive control, EBs, generated from several
of the nontargeted cell clones which had undergone the
selection procedures, were checked for their potential to
differentiate.
The initiation of cardiomyocyte differentiation, as as-
sayed by temporal appearance of rythmically beating car-
diac muscle forming units, seemed to be indistinguishable
in all cell lines regardless of genotype. In desm1//, however,
these cardiocyte aggregates had partially or completely
FIG. 4. Development of cardiac, skeletal, and smooth muscle tis- ceased beating around Day 20 (Fig. 5A). In sharp contrast
sue in differentiating embryoid bodies and timing of desmin gene to this observation, the cardiac muscle in desm1/desm1 EBsexpression. (A) EBs from wild-type ES cell lines AB1 and AB2.1
continue to beat rythmically like in wild-type EBs. Thiswere checked for beating cardiomyocyte units (h), fused myoblasts
early cardiac cell death in heterozygous EBs led to a de-and contracting myotubes (s), and slowly contracting smooth mus-
creased percentage of EBs with beating cardiac cell unitscle cells (n), every day over a period of 33 days. Data points are
between Days 12 and 18 (Fig. 5D). These interesting resultsmean values drawn from 5990 EBs (h), 3471 EBs (s), and 1004 EBs
(n). Each data point represents the mean value of the given day {1 were consistent in six heterozygous and seven homozygous
day to eliminate periodic waves due to the change of medium every cell lines.
3 days. (B) Northern blot analysis of EBs at different stages of devel- The fusion of presumptive myoblasts was reduced in
opment. 25 mg of total RNA was loaded in each lane and probed desm1// EBs and did not occur in desm1/desm1 EBs (Fig. 5B,
with a desmin cDNA fragment. (C) Western blot analysis of inter- peak I). The development of primary or embryonic myo-
mediate ®lament preparations from 4- to 9-day-old EBs. Immunode- tubes was not effected in desm1// EBs (Fig. 5B, peak II); how-tection of desmin in intermediate ®lament pellets with antidesmin
ever, the morphology and contraction of these myotubesmAb D3. Heart, desmin standard from mouse hearts.
were altered considerably and within 1 or 2 days these struc-
tures disintegrated (see Fig. 5B). The formation of secondary
FIG. 3. Expression of muscle-speci®c proteins in embryoid bodies. Indirect immuno¯uorescence microscopy of cells in whole mount
EBs, stained with desmin mAb D3 (A, D, and H), myosin heavy chain mAb MF20 (B, C, and E), myoD (F), myogenin mAb (F), smooth
muscle-speci®c a-actin mAb 1A4 (I), and calponin mab (J). (A and B) Cardiocytes from beating areas in EBs; note cell borders in ®ber-like
cardiocytes in (B) (arrowheads). (C) Cardiocyte aggregates, corresponding to Fig. 2D. (D±F) Polynucleated myotubes; and (G and H) smooth
muscle cells from contracting areas. Bars, 10 mm.
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myotubes (Fig. 5B, peak III) was reduced in desm1// EBs. The blasts or during their differentiation. To distinguish be-
tween these possibilities, we investigated the expression ofdesm1/desm1 EBs were unable to form any myotubes (Fig.
5B). A detailed examination of the embryoid bodies of the myf5, the ®rst myogenic factor detected during myognesis,
in the desmin null EBs. As shown in Fig. 7B, the majoritythree genotypes showed that the desm1// EBs had reduced
cell fusion (Fig. 5E, white bars) and reduced formation of of these cells were myf5 negative. There was, however, a
minor population of cells with Myf5 signals slightly abovelarge polynucleated myotubes (Fig. 5E, striated bars),
whereas the number of small oligonucleated myotubes was background (Fig. 7C) and only few individual cells with
normal myf5 levels (Fig. 7D). These data suggested that incomparable with that seen in des//des/ controls (Fig. 5E,
black bars). In desmin desm1/desm1 EBs the fusion of pre- the absence of desmin the spindle-shaped cells do not syn-
thesize myf5, or if they do the majority is quickly degraded.sumptive myoblasts and formation of myotubes was com-
pletely blocked (Fig. 5E). Similar immuno¯uoresence studies with the available
smooth muscle markers throughout the desm1/desm1 EBsSmooth muscle formation was also reduced in desm1//
EBs and completely inhibited in desm1/desm1 EBs (Fig. 5C). demonstrated the complete absence of smooth muscle actin
and calponin expression (Fig. 8). These data demonstrateThe observed delay in the onset of smooth muscle contrac-
tion in desm1// EBs seemed to be caused by the selection that in the absence of desmin, skeletal and smooth muscle
myogenesis is completely inhibited.procedure, because des//des/ EBs with random integrations
of the targeting vector showed a similar phenomenon.
The effect of reduced desmin levels in desm1// EBs was
investigated more closely. Primary myotubes formed in DISCUSSION
these EBs developed large vacuoles prior to disintegration
(Fig. 6B). Reduced expression of desmin did not seem to Desmin is Dispensable for Early Cardiocyte
inhibit signi®cantly the function of the contractile appara- Differentiation in EBs
tus itself, because the cytoplasm in between vacuoles of
collapsed myotubes occasionally contracted. Very few large, The recent in vitro studies using desmin antisense RNA
demonstrated that at least in the C2C12 cell system desminpolynucleated myotubes were formed in desm1// EBs (Fig.
5B). In desm1/desm1 EBs a large number of spindle-shaped is very important for skeletal myogenesis (Li et al., 1994).
The very early onset of desmin expression during mousecells were found in areas where myotubes are formed in
wild-type EBs (Fig. 6C). These spindle cells (Colley et al., embryogenesis and the fact that desmin is the only muscle-
speci®c protein which is expressed in all three muscle tis-1990) are also seen in wild-type EBs surrounding areas of
myotubes. These cells stain with desmin, MyoD, and myo- sues led us to the hypothesis that desmin might indeed play
one or more vital roles during early steps of myogenic cellgenin antibodies (Figs. 6E±6G) and they do not yet express
myosin heavy chain (data not shown), suggesting that they commitment and differentiation as well as terminal differ-
entiation. To reexamine the role of desmin in cardiogenesisare myoblasts. As expected, no desmin staining could be
seen in desm1/desm1 EB spindle cells (Fig. 6H). Immuno¯uo- and myogenesis, respectively, we mutated the desmin gene
in ES cells by homologous recombination and demonstratedrescence studies failed to detect myosin heavy chain, myoD,
or myogenin protein in the spindle cell populations of des- that in contrast to early cardiocyte differentiation, desmin is
very crucial for skeletal and smooth muscle differentiation.min null mutant EBs (Figs. 6I±6K, respectively). This sup-
pression of myoD and myogenin expression in the spindle- The heart rudiment is the ®rst muscle where desmin is
expressed in mouse embryos at 8 to 8.5 d.p.c. However, theshaped cells implies that desmin is required in some
important process either during the establishment of myo- development of rythmically beating cardiocytes in EBs was
FIG. 5. Inhibition of myogenesis in desmin mutant embryoid bodies. (A±C) EBs from wild-type ES cells (///), from cells with one or
more random integrations of the targeting vector ptkneodes (///Gr), from cell lines with one desmin allele mutated, desm1// (//0), and
from cell lines with both desmin alleles mutated, desm1/desm1 (0/0), were monitored for cardiocytes, myotubes, and smooth muscle for
a period of 33 days. Each data point represents the mean value of the given day {1 day to eliminate periodic waves due to the change of
medium every 3 days. (A) Cardiocyte formation in desmin null mutant EBs. EBs were monitored for beating cardiocyte aggregates. Number
of cell lines and embryoid bodies, respectively, checked: /// n  2, EB n  5990; ///Gr n  5, EB n  3551; //0 n  6, EB n  4107;
0/0 n  7, EB n  2942. (B) Myotube formation in desmin null mutant EBs. EBs were monitored for fused cells (peak I) and polynucleated,
contracting myotubes (peaks II and III). Number of cell lines and embryoid bodies, respectively, checked, /// n  2, EB n  3471; (//
/Gr), 5/1185; (//0), 5/4502; (0/0), 7/4404. (C) Development of smooth muscle cells in desmin null mutant EBs. EBs were monitored for
areas of slowly contracting smooth muscle cell aggregates. Number of cell lines and embryoid bodies, respectively, checked: /// n  2,
EB n  1004; ///Gr n  4, EB n  1268; //0 n  5, EB n  1788; 0/0 n  7, EB n  3665. (D±F) Comparison of EBs with beating
cardiocytes, myotubes, and smooth muscle cells from wild-type ES cells (///), from cells with one or more random integrations of the
targeting vector ptkneodes (///Gr), and from desm1// cell (//0) or desm1/desm1 (0/0) cell lines. Mean values were calculated from peak
maxima as shown in (A±C). (D) Percentage EBs with beating cardiocyte aggregates; data sampled from day 12 to 18. (E) Percentage EBs
with early fusing cells (peak I), small contracting myotubes (peak II), and large, polynucleated, myotubes (peak III); data sampled from
Days 7±13, 14±20, and 23±29, respectively. (F) Percentage EBs with contracting smooth muscle cells; data sampled from Day 20 to 31.
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indistinguishable between embryoid bodies of the three ge- been shown that vimentin is also required for normal levels
of cholesterol esters (Sarrai et al., 1992). It would be verynotypes. Thus the absence of desmin did not have any func-
tional consequences on cardiocyte differentiation and con- important to address such issues in the present desmin null
cardiocytes as well as in the vimentin and GFAP null mice.traction in vitro. It should be noted, however, that in desm1//
EBs the cardiocyte aggregates started disappearing by Day
11, whereas in wild-type and surprisingly in desm1/desm1
Desmin Plays a Crucial Role in Skeletal andEBs they could be detected at least until Day 20. In addition,
Smooth Muscle Developmentin the desm1// EBs the frequency of beating was signi®cantly
reduced. On the other hand, a severe reduction in the num- In contrast to cardiocyte differentiation, skeletal and
smooth muscle formation was totally blocked in desm1/ber of desm1// EBs with beating cardiocyte aggregates was
demonstrated. Interestingly, EBs with complete absence of desm1 EBs. Very little is known so far about smooth muscle
differentiation and development. At the present, there isdesmin were phenotypically wild type. From these data we
can draw two conclusions. First, desmin does not seem to be only one known gene product, the myocyte enhancer bind-
ing factor-2, MEF2 (Gossett et al., 1989), which in Drosoph-vital for cardiocyte commitment and early differentiation,
including the formation of a contractile apparatus, at least ila seems to be very important for smooth muscle differenti-
ation (Lilly et al., 1995). It is of interest to note that thein this in vitro system. It is possible that vimentin, the
growth-regulated intermediate ®lament protein present in desmin gene is one of the earliest genes to be activated by
MEF2, at least in mammalian skeletal (Li et al., 1993; Lithese cells, can compensate for possible desmin function, at
least for the ®rst 20 days of EB cell differentiation. Second, and Capetanaki, 1994) and cardiac muscle (Kuisk et al.,
1995). A severe phenotype was also observed in desm1// EBs.reduced expression of desmin severely interferes with the
maintenance and performance of newly formed cardiocytes. Expression of reduced levels of desmin was correlated with
a considerable reduction in secondary myotube formation.It has been reported that abnormal accumulation of desmin
correlates with some familial cardio- and skeletal myopa- The myocyte population increased, which can be consid-
ered to re¯ect the reduced fusion potential of desm1// myo-thies (for review see Goeble and Bornemann, 1993). One
might speculate that any alteration in desmin expression blasts. These effects on skeletal myogenesis in desm1// EBs
are consistent with in vitro studies using antisense desminleads to altered regulation of other vital proteins in cardio-
cytes or directly causes an instability of the contractile ap- RNA where partial inhibition of desmin expression disturbs
normal myogenesis in C2C12 cells (Li et al., 1994). In des-paratus which leads to the phenotype of lower beating fre-
quency, arrhythmia, and occasional tachycardia. For rea- min null mutant EBs the fusion of presumptive myoblasts
and the formation of polynucleated myotubes were com-sons unknown at the present, these cells can compensate
complete absence of desmin but not reduced expression. It pletely blocked similar to the block of differentiation in
C2C12 cell cultures where antisense desmin RNA was usedcould be speculated that during cell commitment to the
cardiac phenotype, the cell adapts in a way that allows the (Li et al., 1994). Spindle-shaped cells accumulated in desm1/
desm1 EBs with a temporal pattern which was similar touse of a similar protein, vimentin, to serve its purposes.
When desmin is expressed at half normal levels, these adap- myotube formation in wild-type EBs. Since these cells are
negative for MyoD, myogenin, and myf5 it is impossible totions probably are not deleterious at the beginning, but later
are detremental and the cells perform very poorly. It should assess their identity. We cannot really say if these cells are
determined myoblasts or not. Consequently, we can onlybe noted here that recent reports with vimentin null mice
suggested that the absence of vimentin was most possibly speculate that the loss of desmin either blocks directly some
speci®c step during early myogenic commitment and differ-compensated by other IFs that are normally coexpressed
with this IF protein (Colucci-Guyon et al., 1994). The same entiation or alternatively it interferes with the maintenance
of the myogenic phenotype. How could desmin be involvedcompensatory mechanism might explain the absence of any
obvious abnormal phenotype in the recently reported glial in these processes? Myogenesis can be divided into several
phases, including cell commitment, exit from the cell cycle,®brillary acidic protein (GFAP) null mice (Gomi et al.,
1995). On the other hand there are many functions in the initiation of differentiation, cell recognition and alignment,
cell adhesion, and cell fusion (for review see Wakelam,cell that might not have been compensated and have not
been investigated in the above cases. It was recently shown 1985). During most of these processes extensive signal
transduction from the cell surface to the nucleus takesthat biosynthesis of glycosphingolipids is reduced in the
absence of vimentin (Gillard et al., 1994). Similarly, it has place. Desmin could actively participate in one or more
FIG. 6. The desmin gene knockout blocks myotube formation. (A) Polynucleated myotubes in wild-type EBs. (B) Myotubes formed in
desm1// (//0) EBs are ®lled with large vacuoles (arrow) and shrivel within 1 or 2 days after fusion (arrowheads). (C) Spindle-shaped
presumptive myoblasts accumulate in desm1/desm1 (0/0) EBs, which show no sign of myoblast fusion and myotube formation. (D) Wild-
type myotubes stain positive with desmin mAb D3, whereas no desmin positive cells were found in desmin null mutant (H). Spindle-
shaped myoblasts in wild-type EBs express desmin (E), myoD (F), and myogenin (G). Desmin (H), myosin heavy chain (I), myoD (J), and
myogenin (K) can not be detected in desmin null mutant EBs. (A±C) phase-contrast optics: (D±K) indirect immuno¯uorescence microscopy.
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of these processes. If desmin, indeed, somehow modulates
signals that lead to a postmitotic state, this could explain
the absence of an obvious effect during cardiac cell differen-
tiation, since these cells, in contrast to skeletal myoblasts,
can both proliferate and differentiate simultaneously (for
review see Olson, 1993 and Lassar and Munsterberg, 1994).
If desmin is involved in cell recognition or attachment pro-
cesses rather than fusion itself, this might explain why
smooth muscle development is also severely inhibited in
desmin null mutant EBs, since these cells do not fuse. Des-
min, through its interaction with the membrane skeleton
(for review see Lazarides and Capetanaki, 1986; Nelson and
Lazarides, 1984; Georgatos et al., 1987) and particularly
with components of the costameres (Tokuyasu et al.,
1983a,b; for review see Price, 1992), might be involved in
integrating and stabilizing several of their potential func-
tions, including cell recognition, adhesion, and signal trans-
duction. Adhesion molecules and receptors have already
been reported to play important role(s) in myogenesis
(Menko and Boettinger, 1987; Rosen et al., 1992; Holt et
al., 1994). Finally, desmin could be directly involved in
myoblast fusion. This possibility could be favored by several
reported observations. Ectopic expression of desmin in the
lenses of transgenic mice causes, among other abnormali-
ties, partial plasma membrane fusion (Krimpenfort et al.,
1988; Dunia et al., 1990). Furthermore, our previous anti-
sense studies (Li et al., 1994) as well as those from other
investigators (Choi et al., 1990; Lin et al., 1994) have sug-
gested that fusion can take place only between desmin-
positive cells. Finally, the correct quantity of desmin seems
to be necessary for maintaining the phenotype in newly
formed myotubes, because reduced levels of desmin protein
in desm1// EBs caused a collapse of most myotubes.
Potential Mechanisms of Control of the Myogenic
HLH Regulators by the IF Cytoskeleton
The present data clearly demonstrated that in the absence
of desmin the expression of the mHLH regulators is su-
pressed. Therefore, it could be speculated that desmin regu-
lates myogenesis by in¯uencing nuclear events, possibly
through its potential involvement in myogenic signal trans-
duction and transport processes between the cell surface
and the nucleus. This could be a way by which this part of
the cytoskeleton can participate in the establishment and
maintenance of the myogenic phenotype, in the initiation of
differentiation, fusion, and maintenance of the terminally
differentiated state. As pointed out above, desmin could be
responsible for one or more of these processes. However,
the observation that the absence of desmin causes also su-
FIG. 7. Myf5 is signi®cantly inhibited in the absence of desmin.
Indirect immuno¯uorescence microscopy in whole mount EBs
from wild-type (///) (A) or desm1/desm1 (0/0) (B±D) ES cells,
stained with myf5 antibodies. B±D represent approximately 80, 20,
and 1% of the 0/0 spindle-shaped cell population, respectively.
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FIG. 8. Smooth muscle differentiation is blocked in the absence of desmin. Indirect immuno¯uorescence microscopy in whole mount
EBs from wild-type (///) or desm1/desm1 (0/0) ES cells, stained with desmin (A and D), calponin (B and E) and smooth muscle actin (C
and F).
pression of myf5, the only member of the myoD family to tion of at least myoD and myogenin was at the RNA level.
It is possible that desmin might be involved in the nuclearbe expressed in the mouse embryo as early as desmin and
prior to muscle cell differentiation (Smith et al., 1994), sug- transport or stabilization of the RNA or protein of these
factors and when this process is blocked, even partially,gests that desmin must not participate mainly in terminal
differentiation of skeletal muscle but rather acts upstream these proteins cannot ef®ciently transactivate their own
genes and their downstream partners and are quickly de-in processes crucial for the establishment and maintenance
of the myogenic phenotype. The present data do not address graded. A careful analysis of myf5 expression in the desmin
null spindle-shaped cells of the EBs shows that a small frac-directly the mechanism of suppression of the mHLH fac-
tors. The desmin antisense studies showed that the inhibi- tion of them do seem to express low levels of this factor
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Hybridoma supernatants with antibodies D3 and MF-20 were ob-(Figs. 7B±7D). If stabilization is a level at which desmin
tained from the Developmental Studies Hybridoma Bank, Univer-might function, this low signal might be due to residual
sity of Iowa. This work was supported by NIH Grant AR 39617-myf5 protein. Alternatively, it might be possible that des-
01 to Y.C. and a Max Kade award to G.W.min directly in¯uences nuclear events, including the acti-
vation of the mHLH factors, through its connection to the
nuclear matrix-associated lamins (Georgatos and Blobel,
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